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ABSTRACT
The aim of this review is to show the significant role of HIF-1alpha in inflammatory and 
infectious diseases. Hypoxia is a physiological characteristic of a wide range of diseases from 
cancer to infection. Cellular hypoxia is sensed by oxygen-sensitive hydrolase enzymes, which 
control the protein stability of hypoxia-inducible factor alpha 1 (HIF-1alpha) transcription 
factors. When stabilized, HIF-1alpha binds with its cofactors to HIF-responsive elements 
(HREs) in the promoters of target genes to organize a broad ranging transcriptional program 
in response to the hypoxic environment. HIF-1alpha also plays a regulatory function in 
response to a diversity of molecular signals of infection and inflammation even under 
normoxic conditions. HIF-1alpha is stimulated by pro-inflammatory cytokines, growth 
factors and a wide range of infections. Its induction is a general element of the host response 
to infection. In this review, we also discuss recent advances in knowledge on HIF-1alpha 
and inflammatory responses, as well as its direct influence in infectious diseases caused by 
bacteria, virus, protozoan parasites and fungi.
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CRITERIA FOR LITERATURE SEARCH
Literature search was conducted to identify articles on the HIF-1alpha role in 
infectious diseases. The following search terms were entered into two electronic 
databases (Medline via PubMed and SciELO): HIF-1alpha (HIF), HIF and sepsis; 
HIF and bacteria; HIF and Pseudomonas; HIF and E.coli; HIF and S. aureus; HIF 
and Salmonella; HIF and virus; HIF and protozoan parasites; HIF and fungi and 
HIF and cancer, with language restriction for English language articles from 1995 
to 2017. Reference lists of relevant studies were reviewed to identify additional 
studies not found by the initial search.
In the first part of the study, 130 articles that could be useful to this review 
work were found.
Three screening levels for eligibility were performed. The first screening level 
was performed using titles and abstracts, excluding references that did not contain 
information on HIF-1alpha and infectious diseases, did not discuss concepts on 
HIF-1alpha restricted to HIF expression in hypoxic environments. A second screening 
level, also based on titles and abstracts, was performed. This level was restricted 
to results of specific topics, such as: sepsis, bacteria, virus, protozoan parasites 
and fungi. The final screening level was performed using the full-text publications 
and identified studies with the information required to specific pathogens: 
Enterobacteriaceae sp, Escherichia coli, Chlamydia trachomatis, Pseudomonas 
aeruginosa, group A Streptococcus, Yersinia enterocolitica, Salmonella, Bartonella 
Santos et al.
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henselae, Shigella flexneri, Mycobacterium tuberculosis, 
Staphylococcus aureus, Helicobacter pylori, Hepatitis 
C virus, Human papillomaviruses, Toxoplasma gondii, 
Leishmania sp, Aspergillus fumigatus, Candida albicans, 
Histoplasma capsulatum and Coccidioides immitis. 
Full text of publications that met all eligibility criteria 
underwent data extraction. After careful analysis, we chose 
66 articles to make up the final database of the study.
CONCEPTS ON HIF-1ALPHA 
Earth’s atmosphere changed from an anoxic state to 
an oxygenated state two billion years ago. This event 
contributed to the biological diversification when oxygen 
was supplied as free energy for living creatures. Nowadays, 
all eukaryotes from simple yeasts to highly developed 
humans depend mainly on molecular oxygen1.
The transcription factor HIF-1alpha was first identified 
in 19952 and, since its detection, it has been associated with 
several types of disease from cancer to infection. Cells 
under oxygen levels lower than physiological undertake a 
diversity of biological responses in order to adapt to these 
critical conditions. Hypoxic cells respond by increasing the 
expression of various genes that will help survival under 
these situations. The main cellular response manager to low 
oxygen levels is HIF-1alpha3,4. Upon hypoxia, cells react 
by increasing the expression of genes encoding proteins 
that facilitate oxygen supply (e.g., erythropoietin, VEGF) 
or improve anaerobic production of energy (e.g., glycolytic 
enzymes). 
The importance of HIF-1alpha in mammalian 
development can be seen by noting that its absence is 
lethal for embryogenesis, in part because of defective 
vascularization. HIF-1alpha activation can have adaptive 
roles in a diversity of pathological conditions: HIF-1alpha 
allows revascularization after cardiac and cerebral ischemia, 
but it also favors tumor growth in hypoxic environments 
by promoting angiogenesis and metabolic adaptations to 
hypoxia5. 
Another relevant finding is that HIF-1alpha pathway is 
present in almost all cell types and all higher eukaryotes6. 
HIF complex supports the expression of genes such as 
erythropoietin (EPO) by binding to hypoxia-responsive 
enhancer elements (HREs)7.
In humans, three different subunits, HIF-1alpha, 
HIF-2alpha, and HIF-3alpha have been recognized. 
Structurally related and close subunits share a unique 
O2-dependent degradation domain (ODDD). Central to the 
ODDD function are proline residues (two for HIF-1alpha 
and HIF-2alpha, and one for HIF-3alpha)8.
HIF-1alpha activity is closely regulated by oxygen-
dependent control of the cell. In oxygenated states, 
HIF-1alpha is quickly degraded in an ubiquitin dependent 
way and its degradation is mediated by hydroxylation 
on Pro-402 and -564. A family of prolyl hydroxylases 
(PHDs) modifies the subunit HIF-1alpha, turning HIF into 
a target of its degradation. The proline hydroxylases that 
change HIF-1alpha are also Fe2+-dependent and oxygen-
dependent. PHDs use molecular oxygen to hydroxylate 
specific proline residues placed in the conserved motif 
LxxLAP. The produced hydroxyproline residues are 
recognized by the von Hippel-Lindau (VHL) tumor 
suppressor protein that is a component of a multiprotein E3 
ubiquitin ligase complex. HIF-1alpha is not degraded under 
hypoxic conditions, and the stable protein dimerizes with 
HIF-1alpha constitutively expressed in the nucleus. The 
active HIF-1alpha heterodimer binds to related promoter 
elements and also to DNA for activation of its target genes. 
This event leads to expression of hypoxia-inducible proteins 
such as vascular endothelial growth factor, erythropoietin, 
and nitric oxide synthetase5,9,10. Expression and stability of 
HIF-1alpha under normoxic conditions can also be regulated 
by main signal transduction pathways induced by growth 
factors and cytokines, including those related to PI3K and 
ERK/ MAPK9,10.
HIF acts on late cell death induced by hypoxia. 
HIF-1alpha activates late death in cortical neurons by 
a p53-dependent pathway, thus defining an important 
regulating element of ischemic cell death7.
The hypoxic response is important for the function 
of tissue macrophages and infiltrating neutrophils that 
find low O2 pressure in infected tissues. HIF-1alpha was 
also suggested to promote expression of inflammatory 
cytokines in macrophages stimulated with LPS to induce 
cytokines production through the regulation of NF-kB. 
Some studies show that transcriptional activation of 
HIF-1alpha gene by IKKβ-responsive NF-κB is of 
significant value under important pathological conditions 
ex vivo and in vivo. Both, macrophages infected with 
bacteria and mice exposed to hypoxia reveal a prominent 
HIF-1alpha induction defect upon loss of IKKβ. NF-κB is 
also a hypoxia-regulated transcription factor that controls 
HIF-1alpha expression and serves as a main regulator 
of the hypoxic response. NF-κB can enhance glycolytic 
energy metabolism and production of angiogenic factors 
by controlling HIF-1alpha activation in macrophages 
during microbial infections, besides its well-established 
role in the expression of pro-inflammatory cytokines, 
chemokines and anti-microbial peptides. The ability of 
NF-κB to support HIF-1alpha activation during hypoxia 
expands its pro-survival function, since the HIF-1alpha-
dependent hypoxic response is important for providing 
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cells and tissues under ischemia with enough energy 
supplies, allowing them to resist cell death11.
A recent study has suggested that HIF-1alpha activation 
can also occur in response to infections with human 
pathogens12. Up to now, a number of Enterobacteriaceae 
species13, including Escherichia coli14, Chlamydia 
trachomatis15, Pseudomonas aeruginosa16,17, and group A 
Streptococcus18 have been shown to stabilize HIF-1alpha in 
both epithelial and immune cells. HIF-1alpha stabilization 
and its subsequent activation support the discharge of 
antimicrobial peptides, such as cathelicidins and granule 
proteases, enhancing the production of nitric oxide and 
tumor necrosis factor alpha (TNF-alpha)19,20.
Common mechanisms related to infection such as 
the hypoxic environment created by bacterial oxygen 
consumption have been proposed to be partly responsible 
for the HIF-1alpha activation upon infection. Moreover, 
microbial factors such as chemically synthesized LPS from 
E. coli21 and purified siderophores from Enterobacteriaceae13 
have also been implicated in the HIF-1alpha stabilization.
However, molecular mechanisms on how bacteria 
trigger HIF-1alpha remain unclear. Infection of mice with 
Yersinia enterocolitica led to HIF-1alpha activation in 
Peyer’s patches. Mice with deletion of HIF-1alpha in the 
intestinal epithelium showed a notably higher susceptibility 
to Yersinia enterocolitica infections. This phenomenon 
indicates that bacterial HIF-1alpha activation seems 
to represent a host defense mechanism. Other studies 
with Yersinia enterocolitica, Salmonella enterica subsp 
enterica, or Enterobacter aerogenes with application of 
their siderophores (aerobactin, salmochelin, yersiniabactin) 
showed a dose-dependent HIF-1alpha response in human 
epithelia and endothelia, independent of cellular hypoxia. 
HIF-1alpha activation occurs most likely because of 
inhibition of prolyl hydroxylase activity and is abolished 
upon infection by siderophore-deficient bacteria. Bacterial 
siderophores have a role in HIF-1alpha activation during 
infection with human pathogenic bacteria independently of 
hypoxia. Competition to assimilate iron between bacteria 
and host cells constitutes a good reason for HIF-1alpha 
activation in infectious diseases. On the other hand, it is 
supposed that siderophores of Enterobacteriaceae acting 
as iron chelators can also inhibit HIF-1alpha degradation13.
HIF-1alpha activates autophagy, the natural and 
destructive mechanism of the cell to eliminate unnecessary 
or dysfunctional components. This catabolic pathway 
is involved in cellular homeostasis preservation and 
xenophagy (a specialized form of autophagy implicated 
in intracellular bacteria degradation). Many reports have 
highlighted various roles of autophagy in the regulation 
of cell death, immunity and antimicrobial response in 
mammals. Some bacteria are able to impair xenophagy 
or use it to their survive in cells. This phenomenon seems 
to happen with adherent-invasive E. coli (AIEC) found 
inside autophagosomes of immune and epithelial cells. 
Intracellular survival of these bacteria leads to increased 
production of inflammatory cytokines. AIEC colonize ileal 
mucosa of patients with Crohn’s disease and play a role in 
Crohn’s pathogenesis by increasing pro-inflammatory and 
pro-angiogenic responses22.
HIF-1ALPHA AND SEPSIS
HIF-1alpha may mediate the functional reprogramming 
of monocytes in sepsis. During human sepsis efficient 
plasticity of monocytes occurs, wherein they changed from 
a pro-inflammatory to an immunosuppressive phenotype, 
while enhancing protective actions like antimicrobial 
activity, phagocytosis and tissue remodeling. This 
phenomenon signals the potential path of its therapeutic 
use as a regulator of human sepsis23.
HIF-1alpha-deficient macrophages have an impaired 
metabolic adaptation to hypoxia resulting in decreased 
motility and migration properties. Moreover, HIF-1alpha-
deficient macrophages show reduced capacity to kill 
bacteria. Although the rate of phagocytic uptake of group 
B Streptococcus was analogous, intracellular killing and 
lysis of this bacterium were impaired when HIF-1alpha 
was genetically ablated24. Other researches using diverse 
pathogens have pointed to a possible role of hypoxia and 
HIF-1alpha in the control of bacterial phagocytosis25.
Sepsis is the main cause of death in intensive care units. 
In this severe clinical condition, an immune response which 
damages the host often occurs, with LPS shared by gram-
negative bacteria acting as a strong activator of immune cells 
via Toll-like receptor 4 (TLR4). HIF-1alpha is activated by 
LPS in a TLR4-dependent way and contributes to cytokines 
activation and lethality in LPS-induced sepsis in vivo.
HIF-1alpha is a decisive determinant of sepsis 
phenotype through the production of inflammatory 
cytokines, including IL-1, IL-4, IL-6, IL-12 and TNF-alpha. 
Excess cytokines may be harmful to the host during early 
sepsis. HIF-1alpha deletion in macrophages is protective 
against LPS-induced mortality and HIF is protective against 
mortality, also preventing clinical progress to hypotension 
and hypothermia26.
Inoculation of live or heat-inactivated gram-
positive bacteria into macrophages induced HIF-1alpha 
transcriptional activity in macrophages. According to these 
results, myeloid deficiency of HIF-1alpha diminished 
cellular motility caused by gram-positive bacterial 
endotoxin as well as pro-inflammatory genes expression 
Santos et al.
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in macrophages. This phenomenon results in decrease of 
sepsis mortality and clinical symptomatology27.
HIF-1alpha activation leads to secretion of VEGF that 
increase markedly the vascular permeability. Inflammation 
and infection are associated with increased vascular 
permeability with tissue edema and vascular leakage ending 
in septic shock. This dangerous clinical condition might be 
caused by bacterial-induced HIF-1alpha activation and by 
VEGF. Therefore, it is not surprising that neutralization 
of HIF-1alpha-regulated VEGF results in intense decrease 
of vascular permeability and mortality in sepsis. Several 
HIF-1alpha-regulated genes have been associated with 
protection of vascular barrier function during inflammation 
and hypoxia27.
Another interesting knowledge indicates that HIF-
1alpha activation under hypoxia increases bactericidal 
activity, and that HIF-1alpha pathways are responsive 
to bacterial stimulation even under normoxia. Some 
functions of myeloid cells as endothelial transmigration 
and respiratory burst activation appear to be independent 
of HIF-1alpha control. On the other hand, this mediator is 
involved in the regulation of specific immune functions, 
including granule proteases, nitric oxide, and cathelicidin 
antimicrobial peptides. Marked reduction of granule 
protease and cathelicidin expression in HIF-1alpha-
deficient neutrophils correlates with reduced bactericidal 
activity in vitro and failure to control infection in vivo. This 
knowledge provides support to new studies uncovering 
a key role for these neutrophil effectors in mammalian 
innate immunity28.
HIF-1ALPHA AND BACTERIA
Infections with the angiogenic bacterium Bartonella 
henselae (bacillary angiomatosis disease) result in 
HIF-1alpha activation both in vitro and in vivo, probably 
via hypoxia-associated metabolic alterations. Activation 
of HIF-1alpha by human pathogenic Enterobacteriaceae 
seems to follow a more general pattern of bacterial 
infections including the induction of iron deficiency in host 
cells by bacterial siderophores due to a hypoxia-independent 
HIF-1alpha activation29.
Shigella flexneri is a gram-negative bacterium 
responsible for intense intestinal end systemic infection in 
humans. These bacteria can reach the liver and other organs 
due to deterioration of the colonic epithelium. In a study 
of our laboratory, Shigella flexneri invaded less cultured 
hepatocytes previously submitted to hypoxia (6.5% O2) 
for 24 h than those cultured under normoxia conditions. 
In this study, HIF-1alpha expression has also enhanced in 
hepatocytes as well as TNF-alpha secretion and apoptosis 
rate. This bacterium was able to invade rat hepatocytes 
and hypoxia has significantly decreased cell invasiveness 
by this bacterium30.
Several host factors contribute to higher expression of 
HIF-1alpha and related immune/metabolic responses during 
Mycobacterium tuberculosis (Mtb) infection both in vitro 
and in vivo. One factor is nitric oxide (NO) which arises 
by action of an inducible NO synthase (NOS2/iNOS) in 
infected murine macrophages. NOS2/iNOS induction may 
result in redistribution of intracellular oxygen and inhibition 
of PHDs (negative controllers of HIF-1alpha) forming a 
positive feedback loop that leads to a sustained high level 
of HIF-1alpha and increases macrophage activation. During 
Mtb infection, expression of NF-κB family members are 
upregulated in macrophages (mouse and rabbit lungs), 
as well as in the granulomas of patients with pulmonary 
tuberculosis. Regarding NF-κB activation, IkappaB kinases 
(IKK) are necessary for the phosphorylation-induced 
degradation of NF-κB inhibitors in response to infection 
and inflammation. IKK-β is also important for HIF-1alpha 
accumulation in macrophages during bacterial infection. 
NF-κB proteins then dimerize and translocate into the 
nucleus to activate the transcription of HIF-1alpha and 
other target genes31.
Several studies have reported the abnormal presence 
of intramucosal Escherichia coli or mucosa-associated 
Escherichia coli with invasive properties in patients with 
Crohn’s disease (CD) or colorectal cancer. Adherent-
invasive Escherichia coli (AIEC) colonize ileal lesions by 
CD and induce local inflammation. HIF-1alpha is highly 
expressed in inflamed ileal epithelium of CD patients 
inducing expression of pro-inflammatory cytokines (IL-1β, 
IL-6 and IL-17), as well as decreased expression of anti-
inflammatory cytokines such as IL-10. CEACAM6, a 
protein that acts as a receptor of AIEC is expressed in 
this particular condition. Using CEABAC 10 transgenic 
mice that express CEACAM6, it was demonstrated that 
AIEC bacteria induce production of HIF-1alpha protein 
and activation of VEGF/VEGFR signaling. Downstream 
analyses on human intestinal epithelial cells silenced 
for HIF-1alpha, highlight the critical role of this protein 
in production of pro-angiogenic factors. This study 
highlights the crucial role of AIEC bacteria as a promoter 
of inflammatory disorders of the gastrointestinal tract and 
offers clear evidence that HIF-1alpha protein plays a main 
role in mediating this effect32. 
HIF-1alpha gene knockdown increased AIEC survival 
in intestinal epithelial cells in another study. AIEC survival 
rate increment was associated with an intense impairment of 
the autophagic flux at the autolysosomal maturation stage. A 
new function for HIF-1alpha in xenophagy linked to AIEC 
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was shown and this phenomenon suggests that co-activation 
of autophagy and HIF1-alpha expression may be a possible 
new therapy to combat AIEC infection in CD patients22.
Pseudomonas aeruginosa cell-free supernatant 
dramatically suppressed HIF-1alpha protein levels. 
Further characterization revealed that HIF-1alpha down-
regulation was dependent on a subclass of key secreted 
factors involved in Pseudomonas aeruginosa pathogenesis. 
These factors are the 2-alkyl-4-quinolone (AQ) quorum 
sensing (QS) signaling molecules and in particular the 
Pseudomonas quinolone signal (PQS)20. The finding 
that Pseudomonas aeruginosa AQ signaling molecules 
suppressed HIF-1alpha protein levels was unexpected, 
because bacterial components had been shown to lead to 
HIF-1alpha protein accumulation. This research was the 
first report on a bacterial factor capable of suppressing 
HIF-1alpha stabilization20.
HIF-1alpha may play a role in the coordinated response 
of airway cells to Staphylococcus aureus (S. aureus) 
infection. S. aureus also lead cells to necrosis rather than 
apoptosis.One main S. aureus infection characteristic 
concerns its ability to favor subsequent infections by gram-
negative bacteria such as P. aeruginosa in cystic fibrosis 
patients33.
The relationship between HIF-1alpha and Staphylococcus 
aureus infections was also shown in another way. 
Transcriptional profiling of HIF-1alpha-deficient HepG2 
and control cells was made by using Staphylococcus aureus 
infections. The expression of 190 genes was influenced, 
being 24 of them regulated via HIF-1alpha, four hours after 
infection. LOX (encoding lysyl oxidase) was one of the 
upregulated genes with a probable impact on the progress 
of S. aureus infection. LOX is an amine oxidase essential 
for biosynthetic cross-linking of extracellular matrix 
components. LOX was upregulated in vitro in different cell 
cultures infected with S. aureus and in kidney abscesses of 
mice infected with S. aureus, as well as in skin samples from 
patients with S. aureus infections. Inhibition of LOX by 
aminopropionitrile (APN) did not affect the bacterial load 
in kidneys or blood, but significantly influenced abscess 
morphology. These data provide evidence for a central role 
of HIF-1alpha-regulated LOX in abscess development34.
HIF-1alpha activation in infectious diseases seems to 
be induced by several overlapping mechanisms, including 
greater oxygen consumption at the site of infection, iron 
deficiency and some bacterial components (e.g., outer 
membrane proteins such as Bartonella adhesin A or LPS 
from E. coli). HIF-1alpha has a protective role in local 
infections being essential for the bactericidal capacity 
of phagocytes besides controlling the systemic spread of 
bacteria17,24. In contrast, HIF-1alpha activation appears to 
be unfavorable in systemic infections leading to higher 
mortality, as occurs in sepsis induced by LPS and S. aureus 
peritonitis models12,26.
HIF-1alpha agonist mimosine can increase the 
capacity of human phagocytes and whole blood to kill 
Staphylococcus aureus in a dose-dependent mode. This 
phenomenon reduces the lesion dimension in a murine 
model of S. aureus skin infection and represents a new 
approach for the treatment of this bacterial infection35.
Helicobacter pylori (H. pylori) induces reactive 
oxygen species (ROS), which are implicated in peptic 
ulcer disease and gastric cancer. Gastric epithelial ROS, 
either endogenous or induced by H. pylori, improve 
normoxic HIF-1alpha expression in gastric mucosa. 
ROS also stimulate a ubiquitous multifunctional protein, 
apurinic/apyrimidinic endonuclease 1 (APE1). There is 
also an important role of ROS-HIF-1alpha axis in VEGF 
production by H. pylori infected gastric epithelial cells. The 
bacterial T4SS has a minor role in H. pylori-induced VEGF 
production by gastric epithelial cells36.
ROS induced by H. pylori stabilize HIF-1alpha in the 
human gastric epithelium under normoxia. HIF-1alpha 
plays a decisive role in carcinogenesis and has been related 
to malignant progression of gastric cancer. Several genes 
encode functional hypoxia-response elements (HREs) in 
their promoters including Mcl1 (Bcl2 family member). 
Cellular ratios of Mcl1, antiapoptotic oncogenic protein 
and tumor suppressor pro-apoptotic protein regulate cell 
destiny by regulating normal cellular growth, cell death 
and oncogenic processes37.
HIF-1ALPHA AND VIRUS
Hepatitis C virus (HCV) protein triggers HIF-1alpha 
by normoxic stabilization of its subunit. The expression 
of HIF-controlled genes is significantly upregulated 
including those coding for glycolytic enzymes. Analogous 
expression of HIF-controlled genes was observed in cell 
lines expressing subgenomic HCV particles encoding either 
structural or nonstructural viral proteins. Stabilization and 
transcriptional HIF-1alpha activation was established in 
Huh-7.5 cells harboring cell culture-derived infectious 
HCV and in liver biopsy samples from patients with chronic 
hepatitis C. The HCV-related HIF-1alpha stabilization was 
unresponsive to antioxidant treatment38.
In a recent report39, it was shown that HCV infection 
causes oxidant-mediated HIF-1alpha stabilization, leading 
to expression of vascular endothelial growth factor 
(VEGF). The relationship among HCV core protein, 
induction of HIF-1alpha and VEGF expression was also 
shown in another research, when the HCV core gene and 
Santos et al.
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HIF-1alpha siRNA were transfected into Huh7.5.1 cells. 
These results demonstrated that induction of HCV core 
gene expression in Huh7.5.1 cells leads to over expression 
and stabilization of HIF-1alpha. In addition, the HIF-1alpha 
activation leads to stimulation of VEGF40. In this last 
study, the authors have also shown that long-term HCV 
protein expression produced depression of mitochondrial 
oxidative phosphorylation. Cell survival was preserved by 
higher use of glucose non-oxidative pathway. This adaptive 
response to HCV-induced mitochondrial injury proved to be 
mediated by stabilization of HIF-1alpha and upregulation of 
glycolytic enzymes. Comparable results were found in two 
different cell culture systems and in liver biopsy specimens 
from HCV-infected patients40.
HIF-1alpha was induced after infection of human 
fibroblasts with human cytomegalovirus (HCMV). HCMV 
irradiated with ultraviolet light (HCMV-U) has also 
provoked this effect, showing that response was caused 
by the interaction of infective virion with the cell, without 
viral gene expression. Increase of HIF-1alpha protein was 
not detected until 9 hours post infection. Infection with 
HCMV-U resulted in increased HIF-1alpha specific RNA, 
and this fact indicates stimulation of transcription41.
Current studies have shown that HIF-1alpha also plays an 
important task in Kaposi’s sarcoma-associated herpesvirus 
(KSHV) reactivation from latency. Specific interaction 
between KSHV viral IFN regulatory factor 3 (vIRF3) and 
the HIF-1alpha subunit led to HIF-1alpha stabilization and 
transcriptional activation, which induced VEGF expression 
and finally facilitated endothelial tube formation. The central 
domain of vIRF3 was sufficient for binding to HIF-1alpha and 
for blocking its degradation under normoxic conditions. This 
fact shows that KSHV has developed a unique mechanism 
to enhance HIF-1alpha protein stability by incorporating a 
viral homologue of cellular IRF gene into its genome, which 
may contribute to viral pathogenesis42.
Human papillomaviruses (HPVs) are non-enveloped 
DNA viruses that persistently infect keratinocytes of 
stratified squamous epithelia. HPVs are related to a diversity 
of malignancies, more than 99% of cervical cancers43. In 
a study, the levels of HIF-1alpha protein was increased in 
hypoxia when HPV oncogenes was present, and this was 
true for all types of risk viruses. Moreover, this increased 
HIF-1alpha induction resulted in increments of some 
effectors downstream of the hypoxic response, suggesting 
that HPV manipulates some aspects of the cellular hypoxic 
response43. HPV-16 E6 and E7 oncoproteins contribute to 
the progress of non-small cell lung cancer (NSCLC) perhaps 
by promoting tumor angiogenesis via HIF-1alpha/VEGF 
pathways, which may serve as potential molecular targets 
for the treatment of HPV-related NSCLC44. 
HIF-1ALPHA AND PROTOZOAN PARASITES
Toxoplasma gondii is an obligate intracellular protozoan 
pathogen. Some studies have presented that genes mediating 
cellular responses to hypoxia were upregulated in Toxoplasma-
infected cells but not in cells infected with Trypanosoma cruzi, 
another intracellular pathogen. Expression of these genes is 
controlled by HIF-1alpha. Toxoplasma infection rapidly 
increased the quantity of HIF1 alpha subunit and activated 
its reporter gene expression. Toxoplasma growth and survival 
was strictly reduced in HIF-1alpha knockout cells at 3% 
oxygen. HIF-1alpha was not required for parasite invasion, 
but it was necessary for parasite cell division and organelle 
preservation at 3% oxygen45. Several authors have found that 
Toxoplasma infection increased the quantity of transcripts 
encoding glycolytic enzymes, glucose transporters, transferrin 
receptor and vascular endothelial growth factor (VEGF)46,47.
Leishmania donovani (LD), a protozoan parasite and 
the causative agent of fatal visceral leishmaniosis lives in 
macrophages within mammalian hosts. In a study, J774 
macrophages were infected with LD and a four-fold increase 
in HIF-1alpha expression was detected. A strong rise in 
HIF-1alpha expression and its nuclear location was also 
shown in peritoneal macrophages and in spleen-derived 
macrophages of LD infected BALB/c mice. A two-fold 
increase in HIF-1alpha mRNA was found in LD-infected 
macrophages suggesting participation of a transcriptional 
mechanism that was confirmed by promoter activity. LD also 
induces HIF-1alpha expression by reducing host cellular iron 
pool to affect prolyl hydroxylase activity, with stabilization 
of HIF-1alpha. These results suggest that LD activates 
HIF-1alpha by dual mechanism for its survival advantage 
within macrophages48.
In another study, it has been shown that hypoxia induced 
macrophages to control Leishmania amazonensis (LA), an 
intracellular parasite that causes cutaneous metastatic lesions. 
Nitric oxide, TNF- alpha, IL-10 or IL-12 are not responsible 
for the decline in parasitism under hypoxia. Reactive oxygen 
species (ROS) are likely to be involved, because treatment 
with antioxidants N-acetylcysteine (NAC) prevents the 
leishmanicidal effect of macrophages under hypoxia. LA 
infection induces macrophages to express HIF-1alpha. Data 
indicate that hypoxia affects microbial activities and protein 
expression of macrophages leading to a phenotype different 
from that found in the counterpart under normoxia conditions, 
which plays a role in modulating LA infection49. 
HIF-1ALPHA AND FUNGI
Aspergillus fumigatus is an opportunistic fungal 
pathogen that causes invasive pulmonary aspergillosis 
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(IPA) in immunocompromised individuals, particularly in 
hematopoietic stem cell transplant recipients and patients 
with acute leukemia50. As a new treatment approach 
for infectious diseases, HIF-1alpha is presently being 
considered as a possible pharmacological target for host 
immune defense51. HIF-1alpha plays a main role in immune 
functions of phagocytes including dendritic cells (DCs). DCs 
are essential cells in anti-A. fumigatus immune responses. 
DCs express the pattern recognition receptor (PRR) 
dectin-1 that is involved in recognition of A. fumigatus52. 
A complex regulatory network organizes inflammatory 
processes following dectin-1 binding, including activation 
of the NF-kB protein complex, a key regulator of cytokine 
production and cell survival. Notably, the cross-talk between 
NF-kB and HIF-1alpha binds cellular responses against 
infection and hypoxia11. Besides, the transcriptional activity 
of HIF-1alpha in DCs varies depending on whether it is 
activated via TLRs or hypoxia53. This fact suggests that the 
influence of HIF-1alpha on the immune response depends 
on oxygen levels and the pathogen activity in the infection 
microenvironment54.
Infection with Aspergillus fumigatus represents a 
major cause of morbidity in lung transplantation receivers 
with mortality rates up to 82%. Infections after lung 
transplantation may also cause obliterative bronchiolitis, 
invasive pulmonary aspergillosis and airway anastomotic 
infections55,56.
HIF-1alpha appears to exert several protective functions 
on mucosal surfaces like defensins production57. The aging 
process prevents normal angiogenic cell mobilization 
and can be restored through the improvement of HIF-1 
activity58. In addition, increased HIF-1alpha activity may 
be effective primarily to prevent chronic rejection in elderly 
transplant recipients59.
HIF-1alpha is implicated in priming innate immune 
system by C. albicans infection, as already mentioned 
above, through cathelicidin-related antimicrobial peptides 
(CRAMP). These elements are a family of polypeptides 
that provide a critical role in innate immune defense 
against bacterial infection. Human cathelicidin LL-37 has 
been shown to have anti-Candida activity60 and inhibits 
Candida adhesion to epithelial surfaces61,62. In the gastro-
intestinal tract, commensal bacteria induced HIF-1alpha 
which was important in mediating resistance to C. albicans 
colonization by promoting CRAMP (Fan et al. 2015). 
CRAMP is a homolog of the human cathelicidin LL-37 
which caused killing of C. albicans in vitro60,63.
Although immunocompetent hosts usually resolve 
Histoplasma capsulatum  (HC) infections with 
minimal symptoms, severe infections can occur in 
immunocompromised individuals. The incidence of 
hypoxia and the importance of HIF-1alpha in dictating 
antimicrobial activity, metabolism, and cytokine generation 
requires considering the role of this transcription factor 
in the response to HC infection. In a study, the authors 
infected myeloid-specific HIF-1alpha knockout mice by 
the pulmonary route with HC. The absence of myeloid 
HIF-1alpha decreased survival and increased fungal load as 
early as day 3 post infection. The collapse of immunity was 
not related to reduction of lung pro-inflammatory protective 
cytokines, but rather to an increase of IL-10. HIF-1alpha 
was important for controlling the progression of infection 
with the fungal pathogen HC by limiting IL-1064.
HIF-1alpha has also a vital role in the macrophage 
response to HC. It was transcriptionally upregulated and 
stabilized in HC infected macrophages under normoxia. 
HIF-1alpha increased the innate response to this fungus 
by modulating the production of IL-10 in macrophages63. 
An interesting finding showed that the HC-induced 
granuloma was hypoxic in liver of mice during disseminated 
histoplasmosis, and HIF-1alpha was transcriptionally 
upregulated in liver and lung tissues homogenates during 
disseminated and pulmonary histoplasmosis, respectively. 
Macrophage was the main cell population in liver granuloma 
and 95% of these were hypoxic and therefore might produce 
HIF-1alpha protein in granulomatous tissue. Phagocytosis 
of HC by macrophage is partially mediated by complement 
receptor 3 (CR3) as shown for other pathogenic fungi. CR3 
synergizes with Dectin-1, the major beta-glucan receptor, 
and orchestrates a pro-inflammatory cytokine response 
via spleen tyrosine kinase (Syk) that might contribute to 
high HIF-1alpha protein levels in infected macrophages64. 
Subsequent studies showed that the presence of HIF-1alpha 
in macrophages is critically essential for a functional innate 
immune response to HC. HIF-1alpha-deficient mice showed 
high mortality, despite the production of pro-inflammatory 
cytokines such as IL-1beta and TNF-alpha, known to be 
significant for effective immune responses64.
There is only one study showing the potential role 
of HIF-1alpha in Coccidioides immitis (CI) infection. 
Differences between immune functions of CI-susceptible 
and -protected mice strains were investigated. Transcription 
of HIF-1alpha and pro-inflammatory cytokines such as 
IFN-gamma and TNF-alpha were increased in resistant 
mice strains, which might favor fungal immunity, and 
IFN-gamma was shown to be protective against CI65.
PERSPECTIVES
Current findings increase the importance of HIF-1alpha 
in regulating immune cell activity. HIF-1alpha activation 
under hypoxia microenvironment enhances bactericidal 
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activity. HIF-1alpha also regulates myeloid cell aggregation, 
invasion, motility and internalization of bacteria through 
effects linked in part to intracellular ATP levels. The 
present knowledge indicates that the initial induction of 
HIF-1alpha is enough to activate a signaling cascade leading 
to enhanced phagocytosis in vitro and in vivo. These data 
raise the possibility that HIF-1alpha itself may have a key 
role in host defense during systemic inflammation, mainly 
when oxygen delivery is impaired.
The current comprehension suggest that a rational 
design of pharmaceutical HIF-1alpha agonists (or vHL 
antagonists) to enhance myeloid cell microbicidal activity 
may represent a new approach for adjunctive therapy of 
complex infections due to antibiotic-resistant pathogens or 
compromised host immunity. HIF-1alpha has become more 
and more investigated as a target against bacterial infections, 
an approach that might be effective against multidrug-
resistant infections. Some authors have encouraged 
discussion of HIF-1alpha modulation as a pharmacologic 
goal for the treatment of chronic inflammatory disorders 
or to increase innate immune function26. Inhibition of 
HIF-1alpha activity may also characterize a new therapeutic 
target for LPS-induced sepsis26.
Tissue hypoxia and HIF-1alpha signaling have been 
implicated in several diseases, turning this pathway into 
an attractive target for therapeutic intervention. Future 
therapeutic strategies aimed at targeting HIF-1alpha to treat 
diseases such as infections, cancer and inflammation will 
depend on better knowledge of the primary biology of these 
conditions, through the use of physiologically pertinent 
disease models. The newer models such as the zebrafish, in 
concert with more traditional cell lines and murine models, 
could help to understand the extent of the effects that HIF 
modulation will produce on cellular physiology. Exploiting 
these relationships, pharmacological stabilization of HIF-
1alpha may increase phagocyte-mediated clearance of 
infectious agents, providing the first evidence for a novel 
approach to to treat bacterial infections by pharmacologically 
augmenting host phagocytic cells function66.
CONCLUSIONS
Several evidences show that HIF-1alpha has a significant 
role in determining the outcome of diseases such as cancer, 
inflammatory and infectious diseases. HIF-1alpha plays a 
regulatory role in reply to a diversity of molecular signals 
of infection and inflammation. HIF-1alpha is also induced 
by pro-inflammatory cytokines, growth factors and a wide 
range of infections, and its production is a general element 
of the host response to infection. There are evidences that 
HIF-1alpha expression influences the outcome of infections 
caused by numerous different agents: bacteria, viruses, fungi 
and protozoa. HIF-1alpha has therefore become increasingly 
investigated as a target against infections, a strategy that may 
be efficient in multidrug-resistant infections.
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